HÉLÈNE SICARD
9Patents
3h-index
9Co-inventors
42Inventor score
Filing activity: Sep 17, 2013 → Jul 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10174112B2 | Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma | Physics | 8 | Active |
| US10246510B2 | KIR3DL2 binding agents | Physics | 7 | Active |
| US10577419B2 | KIR3DL2 binding agents | Physics | 6 | Active |
| US10344087B2 | Treatment of peripheral T cell lymphoma | Physics | 3 | Active |
| US11858990B2 | KIR3DL2 binding agents | Physics | 2 | Active |
| US11078275B2 | Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma | Physics | 2 | Active |
| US11970535B2 | Treatment with anti-KIR3DL2 agents | Chemistry; Metallurgy | 0 | Active |
| US11999784B2 | Treatment of peripheral T cell lymphoma | Physics | 0 | Active |
| US12084498B2 | Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.